Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School
Mallinckrodt
Dow
Queensland Health
Teva
Chinese Patent Office
Colorcon

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020632

« Back to Dashboard

NDA 020632 describes MERIDIA, which is a drug marketed by Abbott and is included in one NDA. Additional details are available on the MERIDIA profile page.

The generic ingredient in MERIDIA is sibutramine hydrochloride. There are six drug master file entries for this compound. Additional details are available on the sibutramine hydrochloride profile page.
Summary for 020632
Tradename:MERIDIA
Applicant:Abbott
Ingredient:sibutramine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength5MG
Approval Date:Nov 22, 1997TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength10MG
Approval Date:Nov 22, 1997TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength15MG
Approval Date:Nov 22, 1997TE:RLD:No

Expired US Patents for NDA 020632

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-001 Nov 22, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-002 Nov 22, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-002 Nov 22, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-001 Nov 22, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Mallinckrodt
Argus Health
Fish and Richardson
Cantor Fitzgerald
Healthtrust
Express Scripts
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.